What is Climb Bio, Inc. Common Stock's Market Cap?

Climb Bio, Inc. Common Stock's Market Cap is $913.2M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Enterprise Value?

Climb Bio, Inc. Common Stock's Enterprise Value is $730.1M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's EV / EBITDA?

Climb Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Net Income (TTM)?

Climb Bio, Inc. Common Stock's Net Income (TTM) is -$57.6M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's EBITDA?

Climb Bio, Inc. Common Stock's EBITDA is -$64.6M, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Diluted EPS (TTM)?

Climb Bio, Inc. Common Stock's Diluted EPS (TTM) is -1.00, based on as-reported figures from SEC (XBRL) filings.

What is Climb Bio, Inc. Common Stock's Net Debt?

Climb Bio, Inc. Common Stock's Net Debt is -$183.1M, based on as-reported figures from SEC (XBRL) filings.

Climb Bio, Inc. Common Stock (CLYM) Financial Statements

Climb Bio, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZNKL0L5

XNAS · usd

15.90▲ 0.38 (2.45%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close15.52

Day's Range15.13 – 16.08

52-Week Range1.54 – 18.33

Volume894.2K

Avg Volume1.4M

Share Statistics

Shares Outstanding

Employees29

ExchangeXNAS

Listed2021-08-10

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Climb Bio, Inc. Common Stock (CLYM)

What is Climb Bio, Inc. Common Stock's Market Cap?: Climb Bio, Inc. Common Stock's Market Cap is $913.2M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Enterprise Value?: Climb Bio, Inc. Common Stock's Enterprise Value is $730.1M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's EV / EBITDA?: Climb Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Net Income (TTM)?: Climb Bio, Inc. Common Stock's Net Income (TTM) is -$57.6M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's EBITDA?: Climb Bio, Inc. Common Stock's EBITDA is -$64.6M, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Diluted EPS (TTM)?: Climb Bio, Inc. Common Stock's Diluted EPS (TTM) is -1.00, based on as-reported figures from SEC (XBRL) filings.
What is Climb Bio, Inc. Common Stock's Net Debt?: Climb Bio, Inc. Common Stock's Net Debt is -$183.1M, based on as-reported figures from SEC (XBRL) filings.